Sellers are not the blame. No revenue/rev estimates, valuation, bs talk and no substantial results continue to lead the way to lower pps. Management unable to convince the market the company is a solid investment. We need a few credible experienced heavy hitters to unlock the value if there is any at this point! How many more excuses before we dive into the single digits!! The failures are adding up and even with success trust could be a future concern for the market !
(2)
(1)
Generex Biotechnology Corp. (GNBTQ) Stock Research Links